Skip to main content
SpringerLink
Log in

Prognostic variables in patients with prostate cancer: Influence of blood group ABO (H), the rhesus system, age, differentiation, tumour stage and metastases

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Among 279 patients with carcinoma of the prostate no relationship was observed in survival between blood groups ABO (H) or the rhesus system. Age at diagnosis is relevant for the outcome of the disease, but grade of differentiation, tumour stage and metastases are more important predictors of survival.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Benson, M. C., Kaplan, S. A., Olsson, C. A.: Prostate cancer in men less than 45 years old: Influence of stage, grade and therapy.J. Urol., 137, 888 (1987).

    PubMed  CAS  Google Scholar 

  2. Byar, D. P. and the Veterans Administration Cooperative Urological Research Group. Survival of patients with incidentally found microscopic cancer of the prostate: results of a clinical trial of conservative treatment.J. Urol., 108, 908 (1972).

    PubMed  CAS  Google Scholar 

  3. Byar, D. P., Mostofi, F. K.: The Veterans Administration Cooperative Urological Research Group. Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies.Cancer, 30, 5 (1972).

    Article  PubMed  CAS  Google Scholar 

  4. Catalona, W. J., Scott, W. W.: Carcinoma of the prostate. In: M. F. Campbell (ed.): Urology. 5th ed. W. B. Saunders Co., Philadelphia 1986, pp. 1463–1534.

    Google Scholar 

  5. Corriere, J. N., Cornog, J. L., Murphy, J. J.: Prognosis in patients with carcinoma of the prostate.Cancer, 25, 911 (1970).

    Article  PubMed  Google Scholar 

  6. Goodman, C. M., Busuttil, A., Chisholm, G. D.: Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate.Br. J. Urol., 62, 576 (1988).

    PubMed  CAS  Google Scholar 

  7. Handley, R., Carr, T. W., Travis, C. D., Powell, P. H., Hall, R. R.: Deferred treatment for prostate cancer.Br. J. Urol., 62, 249 (1988).

    PubMed  CAS  Google Scholar 

  8. Kvist, E., Raabye, P., Andreasen, K.: Relationship between blood groups and bladder tumors.Scand. J. Urol. Nephrol., 23, 279 (1989).

    PubMed  CAS  Google Scholar 

  9. Kvist, E., Krogh, J., Rye, B.: Blood groups and urothelial tumours of the upper urinary tract. A study of 295 patients.Scand. J. Urol. Nephrol., 24, 253 (1990).

    PubMed  CAS  Google Scholar 

  10. Langman, J.: Medical Embryology. Third edition. The Williams and Wilkins Company, Baltimore-London 1975, pp. 169–187.

    Google Scholar 

  11. Morote, J., Ruibal, A., Pascual, C., Palou, J., Torres, J. A.: Bone marrow prostatic antigen and prostatic acid phosphatase levels: are they helpful in staging prostatic cancer.J. Urol., 137, 891 (1987).

    PubMed  CAS  Google Scholar 

  12. Neill, W., Norval, M., Habib, F. K.: Nuclear analysis of prostate tissues: Correlation with stage and grade of tumour.Urol. Int., 44, 141 (1989).

    Article  PubMed  CAS  Google Scholar 

  13. Nissen, H. M., Mathiesen, F. R., Grau, V.: The prognosis in carcinoma of the prostate, judged on the basis of clinical classification into stages and histological grading.Int. Urol. Nephrol., 9, 17 (1977).

    Article  PubMed  CAS  Google Scholar 

  14. Surya, B. V., Provet, J. A.: Manifestations of advanced prostate cancer: Prognosis and treatment.J. Urol., 142, 921 (1989).

    PubMed  CAS  Google Scholar 

  15. Turowska, B., Lenko, J., Turowski, G.: Blood groups, serum proteins and enzymes in patients with carcinoma of the prostate.Acta Med. Pol., 23, 105 (1982).

    PubMed  CAS  Google Scholar 

  16. Vesey, S. G., Goble, N. M., Stower, M. J., Hammonds, J. C., Smith, J. B.: The effects of transurethral prostatectomy on serum prostate specific antigen.Br. J. Urol., 62, 347 (1988).

    Article  PubMed  CAS  Google Scholar 

  17. Veterans Administration Cooperative Urological Research Group. Factors in the prognosis of carcinoma of the prostate: A cooperative study.J. Urol., 100, 59 (1968).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark

    E. Kvist, J. Krogh & P. Hjortberg

Authors
  1. E. Kvist
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Krogh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. Hjortberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kvist, E., Krogh, J. & Hjortberg, P. Prognostic variables in patients with prostate cancer: Influence of blood group ABO (H), the rhesus system, age, differentiation, tumour stage and metastases. International Urology and Nephrology 24, 417–423 (1992). https://doi.org/10.1007/BF02550636

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550636

Keywords

Search

Navigation